Atreca's Series A Round

Atreca raised a round of funding on November 04, 2015.

Atreca is a privately held biotechnology company developing therapeutics drawn from human immune responses, including effective anti-cancer immune responses. The company is able to measure and analyze…

Articles about Atreca's Series A Round: